403 related articles for article (PubMed ID: 19705965)
1. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles.
Bilensoy E; Hincal AA
Expert Opin Drug Deliv; 2009 Nov; 6(11):1161-73. PubMed ID: 19705965
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
3. [Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications].
Parrot-Lopez H; Perret F; Bertino-Ghera B
Ann Pharm Fr; 2010 Jan; 68(1):12-26. PubMed ID: 20176159
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
[TBL] [Abstract][Full Text] [Related]
5. Bilayer vesicles of amphiphilic cyclodextrins: host membranes that recognize guest molecules.
Falvey P; Lim CW; Darcy R; Revermann T; Karst U; Giesbers M; Marcelis AT; Lazar A; Coleman AW; Reinhoudt DN; Ravoo BJ
Chemistry; 2005 Feb; 11(4):1171-80. PubMed ID: 15619722
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic evaluation of injectable cyclodextrin nanoparticles.
Memisoglu-Bilensoy E; Doğan AL; Hincal AA
J Pharm Pharmacol; 2006 May; 58(5):585-9. PubMed ID: 16640826
[TBL] [Abstract][Full Text] [Related]
7. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
[TBL] [Abstract][Full Text] [Related]
8. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
Lakkakula JR; Maçedo Krause RW
Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
[TBL] [Abstract][Full Text] [Related]
9. [Interactions between cyclodextrins and triglycerides: from emulsion stabilisation to the emergence of a new drug delivery system called "beads"].
Hamoudi M; Trichard L; Grossiord JL; Chaminade P; Duchêne D; Le Bas G; Fattal E; Bochot A
Ann Pharm Fr; 2009 Nov; 67(6):391-8. PubMed ID: 19900602
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled cyclodextrin aggregates and nanoparticles.
Messner M; Kurkov SV; Jansook P; Loftsson T
Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrins in drug delivery.
Loftsson T; Jarho P; Másson M; Järvinen T
Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
[TBL] [Abstract][Full Text] [Related]
12. Amphiphilic Cyclodextrin Derivatives for Targeted Drug Delivery to Tumors.
Erdogar N; Varan G; Bilensoy E
Curr Top Med Chem; 2017; 17(13):1521-1528. PubMed ID: 28017158
[TBL] [Abstract][Full Text] [Related]
13. New challenges for pharmaceutical formulations and drug delivery systems characterization using isothermal titration calorimetry.
Bouchemal K
Drug Discov Today; 2008 Nov; 13(21-22):960-72. PubMed ID: 18617012
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrins as pharmaceutical solubilizers.
Brewster ME; Loftsson T
Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
[TBL] [Abstract][Full Text] [Related]
15. Improvement of aqueous solubility of fenretinide and other hydrophobic anti-tumor drugs by complexation with amphiphilic dextrins.
Orienti I; Zuccari G; Carosio R; Montaldo PG
Drug Deliv; 2009 Oct; 16(7):389-98. PubMed ID: 19624248
[TBL] [Abstract][Full Text] [Related]
16. Update for nurse anesthetists--part 3--cyclodextrin introduction to anesthesia practice: form, function, and application.
Welliver M
AANA J; 2007 Aug; 75(4):289-96. PubMed ID: 17711159
[TBL] [Abstract][Full Text] [Related]
17. The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs.
Trapani A; Sitterberg J; Bakowsky U; Kissel T
Int J Pharm; 2009 Jun; 375(1-2):97-106. PubMed ID: 19481695
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals.
Thompson DO
Crit Rev Ther Drug Carrier Syst; 1997; 14(1):1-104. PubMed ID: 9043816
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin based nanosponges for pharmaceutical use: a review.
Tejashri G; Amrita B; Darshana J
Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
[TBL] [Abstract][Full Text] [Related]
20. Progress in developing amphiphilic cyclodextrin-based nanodevices for drug delivery.
Yaméogo JB; Géze A; Choisnard L; Putaux JL; Semdé R; Wouessidjewe D
Curr Top Med Chem; 2014; 14(4):526-41. PubMed ID: 24354667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
